Description: The peptide is used to block Anti-TRK A Antibody (#CPA5063) reactivity. Form: Lyophilized powder Gene Symbol: NTRK1 Alternative Names: MTC; TRK; TRKA; High affinity nerve growth factor receptor; Neurotrophic tyrosine kinase receptor type 1; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor; Tyrosine kinase receptor A; Trk-A; gp140trk; p140-TrkAEntrez Gene (Human): 4914Entrez Gene (Mouse) : 18211Entrez Gene (Rat) : 59109SwissProt (Human): P04629SwissProt (Mouse) : Q3UFB7SwissProt (Rat) : P35739Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.

• 
  Western blot analysis of TRK A expression in HEK293T (A), NIH3T3 (B), mouse heart (C) whole cell lysates.
• 
  Immunohistochemical analysis of TRK A staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.